Loading stock data...

MedPlus Health Services Limited

NSE: MEDPLUS BSE: MEDPLUS

NSE
838.75 7.85 (0.94%)

Prev Close

830.9

Open Price

828.25

Volume

65,190

Today Low / High

828.25 / 841.35

52 WK Low / High

634.8 / 1045.3

Range

797 - 881

BSE
839.20 9.10 (1.10%)

Prev Close

830.1

Open Price

830.9

Volume

1,778

Today Low / High

829.25 / 840.75

52 WK Low / High

603 / 1052.05

Range

797 - 881

The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 838.75 (target range: 797 - 881), reflecting a change of 7.85 (0.94476%). On the BSE, it is listed at 839.2 (target range: 797 - 881), showing a change of 9.1 (1.09625%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.

12 Sep 828.25 1.27%
11 Sep 831.00 -0.01%
10 Sep 830.50 0.07%
09 Sep 834.65 0.08%
08 Sep 832.50 0.28%
05 Sep 841.15 -1.03%
04 Sep 849.80 -0.97%
03 Sep 842.60 0.00%
02 Sep 837.40 1.19%
01 Sep 841.95 -1.06%
29 Aug 832.20 1.17%
28 Aug 849.95 -2.61%
26 Aug 842.00 0.01%
25 Aug 825.60 1.88%
22 Aug 828.55 -0.88%
21 Aug 838.15 -1.15%
20 Aug 835.00 -0.60%
19 Aug 831.00 0.48%
18 Aug 815.10 2.02%

MedPlus Health Services Limited Graph

MedPlus Health Services Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for MedPlus Health Services Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 838.75, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 839.20 847.59 762.83 - 932.35
855.98 684.79 - 1,027.18
864.38 605.06 - 1,123.69
Bearish Scenario 839.20 830.81 747.73 - 913.89
822.42 657.93 - 986.90
814.02 569.82 - 1,058.23

Overview of MedPlus Health Services Limited

ISIN

INE804L01022

Industry

Medical - Pharmaceuticals

Vol.Avg

162,380

Market Cap

100,435,025,859

Last Dividend

0

Official Website

Visit Website

IPO Date

2021-12-23

DCF Diff

391.21

DCF

445

Financial Ratios Every Investor Needs

Stock Rating Details for MEDPLUS

Metric Value Recommendation
Overall Rating C- Strong Sell
DCF Score 4 Buy
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 6,136.05 Cr 5,616.52 Cr 519.53 Cr 0.0847 0.00 Cr 0.00 Cr 237.26 Cr 150.32 Cr 12.58 535.72 Cr 0.0245
2024-03-31 5,624.86 Cr 4,410.52 Cr 1,214.34 Cr 0.2159 0.00 Cr 625.62 Cr 563.51 Cr 65.47 Cr 5.48 394.09 Cr 0.0116
2023-03-31 4,557.58 Cr 3,557.69 Cr 999.89 Cr 0.2194 0.00 Cr 20.95 Cr 96.09 Cr 49.76 Cr 4.17 311.75 Cr 0.0109
2022-03-31 3,755.38 Cr 2,982.38 Cr 773.00 Cr 0.2058 0.00 Cr 16.88 Cr 162.71 Cr 95.80 Cr 8.29 303.73 Cr 0.0255
2021-03-31 3,050.78 Cr 2,425.03 Cr 625.75 Cr 0.2051 0.21 Cr 14.16 Cr 135.32 Cr 63.86 Cr 6.26 238.21 Cr 0.0209

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 367.22 Cr 3,360.10 Cr 1,620.20 Cr 1,740.5610 Cr 1,119.80 Cr 752.58 Cr 1,345.10 Cr 1,261.75 Cr 0.00 Cr 0.00 Cr 92.08 Cr 576.5940 Cr
2024-03-31 91.21 Cr 3,004.80 Cr 1,427.44 Cr 1,577.9320 Cr 1,009.57 Cr 918.36 Cr 1,340.23 Cr 1,202.69 Cr 15.77 Cr 0.00 Cr 5.10 Cr 525.9350 Cr
2023-03-31 228.38 Cr 2,796.72 Cr 1,306.22 Cr 1,491.1780 Cr 899.92 Cr 671.55 Cr 1,144.09 Cr 1,114.44 Cr 103.18 Cr 0.00 Cr 2.21 Cr 476.5830 Cr
2022-03-31 21.46 Cr 2,594.05 Cr 1,176.80 Cr 1,417.7720 Cr 814.94 Cr 793.48 Cr 914.98 Cr 771.48 Cr 85.33 Cr 0.00 Cr -598.94 Cr 559.0120 Cr
2021-03-31 106.82 Cr 1,565.66 Cr 834.55 Cr 730.5530 Cr 590.21 Cr 483.40 Cr 749.96 Cr 477.58 Cr 71.04 Cr 0.00 Cr -42.28 Cr 414.9400 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 554.4070 Cr -331.6450 Cr -227.9190 Cr 494.9570 Cr 276.0090 Cr 367.2180 Cr -59.4500 Cr 150.3220 Cr 0.0000 Cr 0.0000 Cr -4.8650 Cr
2024-03-31 143.7370 Cr -82.7990 Cr -198.1040 Cr 59.3380 Cr -137.1660 Cr 91.2090 Cr -84.3990 Cr 65.4730 Cr 0.0000 Cr 0.0000 Cr -196.1470 Cr
2023-03-31 90.4100 Cr 429.4410 Cr -170.2490 Cr -78.5950 Cr 349.6020 Cr 228.3750 Cr -169.0050 Cr 47.1630 Cr -88.4110 Cr 0.0000 Cr -229.1030 Cr
2022-03-31 169.8890 Cr -703.1260 Cr 440.4290 Cr 52.1680 Cr -92.8080 Cr -121.2270 Cr -117.7210 Cr 117.9430 Cr -65.6380 Cr 0.0000 Cr -165.0270 Cr
2021-03-31 2.8910 Cr -34.5490 Cr -5.6260 Cr -51.3670 Cr -37.2840 Cr -28.4190 Cr -54.2580 Cr 95.0980 Cr 0.0000 Cr 0.0000 Cr -106.4020 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-06-30 1,542.63 Cr 1,139.74 Cr 402.90 Cr 0.2612 65.11 Cr 42.36 Cr 3.54 145.75 Cr 0.0275
2025-03-31 1,509.61 Cr 1,367.02 Cr 142.59 Cr 0.0945 72.17 Cr 51.34 Cr 4.30 152.17 Cr 0.0340
2024-12-31 1,561.45 Cr 1,170.58 Cr 390.86 Cr 0.2503 70.06 Cr 45.89 Cr 3.84 145.04 Cr 0.0294
2024-09-30 1,576.17 Cr 1,201.87 Cr 374.30 Cr 0.2375 61.30 Cr 38.74 Cr 3.24 136.04 Cr 0.0246
2024-06-30 1,488.83 Cr 1,381.42 Cr 107.40 Cr 0.0721 167.43 Cr 14.36 Cr 1.20 93.76 Cr 0.0096

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-03-31 367.22 Cr 0.00 Cr 367.22 Cr 13.27 Cr 1,345.10 Cr 1,843.52 Cr 1,261.75 Cr 3,360.10 Cr 1,620.20 Cr
2024-12-31 0.00 Cr 0.00 Cr 267.60 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -1,635.67 Cr
2024-09-30 123.97 Cr 179.09 Cr 303.07 Cr 17.98 Cr 1,340.71 Cr 1,712.39 Cr 1,190.99 Cr 3,155.07 Cr 1,519.40 Cr
2024-06-30 0.00 Cr 0.00 Cr 174.24 Cr 0.00 Cr 0.00 Cr 174.24 Cr 0.00 Cr 0.00 Cr -1,577.36 Cr
2024-03-31 141.68 Cr 83.03 Cr 141.68 Cr 17.50 Cr 1,340.23 Cr 1,567.55 Cr 1,201.38 Cr 3,004.80 Cr 1,427.44 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2024-12-31 45.89 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 38.74 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 14.36 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-03-31 33.40 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2023-12-31 13.73 Cr 114.22 Cr 0.00 Cr 0.00 Cr 78.21 Cr 198.59 Cr 120.38 Cr 0.00 Cr 114.22 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹838.75 ₹100,435,025,859.00 ₹65,190.00

Key Executives

Chief Strategy Officer
Mr. Chetan Dikshit

Gender: male

Year Born:

Chief Operating Officer & Whole Time Director
Dr. Cherukupalli Bhaskar Reddy

Gender: Not Specified

Year Born:

Head of Corporate Secretarial & Governance, Company Secretary and Compliance Officer
Mr. Manoj Kumar Srivastava

Gender: male

Year Born:

Head of Supply Chain
Mr. Kandasamy Vairaperumal

Gender: male

Year Born:

Chief Financial Officer
Mr. Sujit Kumar Mahato

Gender: male

Year Born:

Founder, Chief Executive Officer, MD & Chairman
Dr. Gangadi Madhukar Reddy

Gender: Not Specified

Year Born: 1967

FAQs about MedPlus Health Services Limited

Who is the CEO of the company?

The CEO is Gangadi Madhukar Reddy.

What is the current market price of the stock?

The current price is ₹838.75.

What is the 52-week price range?

The range is ₹634.8-1045.3.

What is the market capitalization of the company?

The market capitalization is ₹10,043.50 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 56.28.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of MedPlus Health Services Limited (ISIN: INE804L01022) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹10,043.50 crores and an average daily volume of 162,380 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.